US pharmaceutical company Eli Lilly and Company plans to invest over $1 billion in India over the next few years to set up new contract manufacturing facilities and a manufacturing and quality hub in Hyderabad. The investment will also support the company’s supply chain capabilities in India.

Hyderabad hub

The Hyderabad hub will provide technical oversight for Lilly’s contract manufacturing network across the country. Recruitment for the new facilities is expected to start immediately, with openings in engineering, chemistry, analytical science, quality control and assurance, and management roles.

Since 2020, Lilly has invested more than $55 billion globally in building, expanding, and acquiring manufacturing facilities to support medicines for diabetes, obesity, Alzheimer’s disease,

See Full Page